Canada's Export Boom and Dutch Coffeeshop Pragmatism

Photo by Jan van der Wolf via Pexels.

Two data releases landed in the same month, on opposite sides of the Atlantic, and neither one used the word "legalization" in the way most people assume it means. Canada's cannabis exporters shipped more than 275 tonnes of medical-grade product abroad in 2025, a 143% jump over the year before, with Germany absorbing the bulk of it. Around that same time, the Dutch government published the first-year progress report on its Wietexperiment, the pilot program that lets coffeeshops in ten municipalities buy only from licensed, government-tracked growers instead of the unregulated supply chain that's fed them for fifty years.

Neither country is running an open cannabis market. Canada ships plant material out under permits tied strictly to medical and scientific use, bound by international drug treaties it has no intention of breaking. The Netherlands isn't legalizing recreational use at all -- that's been tolerated since the 1970s -- it's legalizing the growing and distribution behind the counter, the part of the system regulators used to pretend not to see. What connects these two stories isn't ideology. It's an instinct both governments landed on independently: keep the supply chain narrow, keep it documented, and let commerce move through the gate you've built rather than pretending the gate doesn't need to exist.

Canada's Export Numbers Tell a Bigger Story

Photo by CRYSTALWEED cannabis via Unsplash.

Start with the raw figure: Canadian licensed producers exported north of 275 tonnes of medical cannabis in 2025, more than double what left the country in 2024. That's not a rounding-error increase -- it's the kind of growth curve that reshapes a sector's export priorities within a single fiscal year. Germany did most of the heavy lifting. Shipments from Canada to Germany rose 298% year-on-year, reflecting Germany's own expanding medical cannabis patient base and its continued reliance on imported flower since domestic cultivation there hasn't scaled fast enough to meet demand.

Germany wasn't alone. Australia, Portugal, Israel, and the United Kingdom all posted meaningful growth as destination markets, each running its own version of a medical cannabis import system that still depends on established foreign suppliers rather than fully domestic production. That's where Canada's structural advantage shows up. Canadian producers operate with lower input costs than most Western European growers -- cheaper land, cheaper power in several provinces, and greenhouse infrastructure built years before most European competitors broke ground.

There's also the matter of time. Standing up a medical-grade cultivation facility that meets EU-GMP standards, or the equivalent regulatory bar in Israel or the UK, takes years of capital investment and regulatory learning that Canadian producers have already absorbed. Companies like Canopy Growth, Tilray, and Aurora Cannabis built out compliance infrastructure during Canada's 2018 legalization rollout and the years of medical-only production before that -- experience that's difficult to buy or replicate quickly, even with capital. That head start, more than any single trade policy, is what's driving the export numbers.

Why Health Canada Keeps a Tight Grip on the Exit Door

Photo by RDNE Stock project via Pexels.

None of that growth happens without Health Canada's export bulletin, which spells out in narrow terms when cannabis shipments are permitted at all. Under the Cannabis Act and its accompanying regulations, exports are authorized only for medical or scientific purposes -- never recreational, and never framed that way in any paperwork that leaves the country. That's not a bureaucratic preference; it's how Canada stays compliant with the UN drug conventions it's signed onto, which still classify cannabis in ways that restrict cross-border recreational trade regardless of what individual countries have done domestically.

The regulatory machinery shifted again in early 2025. Streamlining of Requirements regulations took effect March 12, simplifying some of the administrative steps producers navigate to secure export permits, though Health Canada was still updating its own guidance pages well after the rule change took hold -- a reminder that even streamlining takes time to fully implement inside a government department.

Where the system gets frustrating for industry isn't the permitting rules themselves -- it's what's missing around them. The Trade Commissioner Service, which normally helps Canadian exporters open doors abroad, offers cannabis companies only administrative facilitation. There are no cannabis-focused trade missions, no export credit programs, no bilateral agreements negotiated specifically to smooth Canadian cannabis into new markets the way Canada actively promotes its beef, canola, or aerospace sectors. Producers are left holding strong cultivation and compliance capacity with almost no diplomatic muscle behind it -- a mismatch that shows up every time a competitor with weaker production but stronger government backing wins a contract Canada was better positioned to fill.

The Netherlands' Front-Door Experiment

Photo by wal_ 172619 via Pexels.

The Dutch approach starts from a different problem. For decades, coffeeshops could legally sell small amounts of cannabis to customers under a tolerance policy -- gedoogbeleid -- while the cannabis stocking their shelves was grown and transported entirely outside the law. Regulators tolerated the front door and ignored the back door, an arrangement that worked well enough for a long time but left the entire supply chain in criminal hands and gave municipalities no way to inspect quality, track volume, or verify where product actually came from.

The Wietexperiment -- formally the Controlled Cannabis Supply Chain Experiment -- launched its four-year experimental phase on April 7, 2025, aiming directly at that gap. Coffeeshops in ten designated municipalities, including Breda and Tilburg, may now only sell cannabis sourced from a small set of licensed, government-designated growers whose product is tracked from cultivation through sale. The goal isn't to change what customers can buy or how much -- it's to finally legalize and monitor the part of the chain that's always been left in the dark.

Independent evaluators are watching closely. RAND Europe is assessing the experiment alongside the Netherlands' Trimbos Institute and the research firm Breuer & Intraval, with a full national evaluation scheduled for the end of 2029. That's a long runway by design -- policymakers wanted enough data across enough seasons and enough municipalities to know whether regulated supply actually holds up, rather than drawing conclusions from a rushed pilot. The first-year report released in 2025 was just the opening chapter; the experiment has three more years to run before anyone in The Hague makes a permanent call.

What a Year of Inspections Actually Found

Inspections under the Wietexperiment program rose sharply from just 8 in 2023 to 375 in 2025, reflecting a rapid scale-up in oversight, though 2026 figures so far are only partial.

The numbers from that first year are worth sitting with. Across the ten licensed growers supplying the pilot's coffeeshops, inspectors logged just 42 violations total. Of those, 19 resulted in informal or formal warnings, and only four escalated to fines -- ranging from €1,000 on the low end to €20,000 for more serious infractions. For a brand-new regulated supply chain replacing decades of black-market sourcing, that's a strikingly clean compliance record.

What makes the number more meaningful is how much scrutiny it survived. Inspection activity ramped up fast: just eight inspections were carried out in 2023 during preparatory groundwork, jumping to 145 in 2024 as growers came online, then 375 across 2025 once the experiment was fully live. Early 2026 has already logged 56 more. That's not a system coasting on light oversight -- it's one getting checked constantly, and still turning up relatively few problems.

Breda's mayor, Paul Depla, whose city is one of the ten participating municipalities, has called the rollout a success on practical grounds rather than ideological ones. Customers haven't stopped showing up, coffeeshop sales haven't dropped off, and -- critically for a policy designed to squeeze out illegal supply -- street dealing hasn't resurfaced to fill any gap. Rising inspection counts paired with low violation rates suggest something regulators don't get to say very often about a first-year pilot: the system appears to be functioning close to how it was designed, not merely tolerated on paper while problems pile up out of view.

Two Countries, One Compliance Instinct

Photo by Jess Loiterton via Pexels.

Line up the two systems and the mechanics look almost identical, even though the products being regulated sit at opposite ends of the supply chain. Canada channels every gram of exported cannabis through Health Canada permits bound by UN treaty obligations, restricted to medical and scientific buyers who can document their need. The Netherlands is testing whether legalizing the growing and distribution side of its domestic supply chain -- not personal consumption, which was never really the contested part -- can finally resolve a policy contradiction that's persisted since coffeeshops first opened.

Both governments arrived at the same rejection: neither wanted an all-or-nothing legalization model, the kind that opens a fully free market overnight and hopes regulation catches up later. Instead, both built narrow, monitored channels -- export permits in one case, licensed cultivation contracts in the other -- specifically because those channels can be audited line by line. A permit system means someone can trace every shipment back to its paperwork. A licensed-grower system means every gram sold in a Breda coffeeshop has a documented origin, which simply wasn't true before April 2025.

The throughline is control, not caution for its own sake. Canada isn't chasing a recreational export market, and the Netherlands isn't opening its coffeeshops to a free-for-all supply chain. Both are managing risk while still letting commerce expand inside lanes regulators drew on purpose. Canada's export growth and the Dutch pilot's inspection data are, in their own ways, evidence that tightly controlled pragmatism doesn't just contain a black market -- it can support a real, growing, legitimate one running right alongside where the illegal version used to be.

The lesson sitting inside both of these stories isn't "legalize everything and sort out the details later." It's closer to the opposite: build one narrow channel, make it auditable from top to bottom, and let the market grow inside that channel before you ever consider widening it. Canada's export permits and the Netherlands' licensed-grower contracts are both, functionally, the same tool -- a gate regulators can watch closely, applied to a specific slice of the market rather than the whole thing at once.

Canada's advantage right now is real and earned -- years of cultivation experience, EU-GMP-certified facilities, and lower production costs than most competitors can currently match. But an advantage in capacity isn't the same as an advantage in market access, and the gap between Canadian producers' growing capability and the government's thin trade-promotion support is the kind of thing that erodes quietly. Other exporting nations pairing solid cultivation with active trade diplomacy could close the distance faster than Canadian companies would like.

Both stories have a clear date to watch. The Dutch national evaluation lands in 2029, when RAND Europe, Trimbos, and Breuer & Intraval will say plainly whether licensed supply chains held up over four full years, not just one promising opening stretch. Canada's next export cycle will show whether 2025's growth was a genuine trajectory or a one-year spike tied to Germany's expanding patient base. Put together, they'll answer the real question underneath all this: whether narrow, pragmatic control is a durable policy model, or just a comfortable way to manage a pilot before someone has to make a harder decision.